Univit

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Univit

Quick Facts

Property Description
Active Ingredient Sodium Ascorbate
Form Oral (Tablet/Capsule) or Parenteral (Injection Solution)
Pharmacological Class Water-soluble Vitamin (Vitamin C derivative)
Common Use Prevention and correction of Ascorbic Acid deficiency
Origin Synthetic (Organic sodium salt)

Univit: Classification and Identity of the Active Ingredient

Univit is a medicinal preparation containing Sodium Ascorbate, which is the sodium salt of Ascorbic Acid (Vitamin C). It is fundamentally classified within the high-level pharmacological category of a water-soluble vitamin and is recognized as an essential nutrient derivative required for normal bodily function. The compound, identified chemically as Sodium L-Ascorbate, is an organic sodium salt typically obtained through synthesis. This specific chemical structure provides a buffered, less acidic source of Vitamin C compared to the pure acid form, a feature that is widely accepted in clinical practice to improve patient gastrointestinal tolerance.

Composition and Available Dosage Forms

The composition of Univit features Sodium Ascorbate (CAS Reg. No. 134-03-2) as the sole therapeutic agent in its pure form, classifying it as a single-ingredient preparation and a mineral ascorbate. This ingredient is formulated into several high-level dosage form(s), including preparations for oral administration (tablets or capsules) and sterile aqueous solution preparations designed for parenteral administration (intramuscular or intravenous routes). Its availability in injectable form is clinically recognized as necessary for managing severe deficiency states where oral absorption is compromised or rapid correction is required.

General Purpose and High-Level Physiological Role

The general purpose of Univit is to prevent and correct states of Ascorbic Acid deficiency, such as the condition known as scurvy. Sodium Ascorbate functions physiologically as a powerful reducing agent and antioxidant, helping to safeguard cells from damage induced by oxidative stress. Furthermore, its role as an indispensable cofactor means it is necessary for several key biological processes, including the biosynthesis of collagen, a protein vital for the structural integrity of connective tissues throughout the body.

Regulatory References

  1. MedlinePlus: Vitamin C

What side effects are possible with Univit?

Possible Side Effects and Safety Information for Univit

The safety profile of Univit, based on official regulatory documentation, is characterized by specific categories of adverse reactions and important safety limitations.

Classification of Adverse Reactions

Adverse reactions are classified by the System Organ Class (SOC) affected and by their frequency of occurrence, following established regulatory standards such as CIOMS frequency bands:

Frequency Category Estimated Incidence
Very Common ge 1/10
Common ge 1/100 to < 1/10
Uncommon ge 1/1,000 to < 1/100
Rare ge 1/10,000 to < 1/1,000

Officially documented System Organ Classes affected include Nervous System Disorders, Gastrointestinal Disorders, Cardiac Disorders, and Vascular Disorders. Examples of common reactions include somnolence and fatigue, which may be dose-dependent and more pronounced during early treatment or following dose adjustments.

Serious Adverse Reactions and Safety Limitations

A suspected adverse reaction is defined as Serious if it results in outcomes such as death, a life-threatening event, inpatient hospitalization, or persistent significant disability, requiring expedited reporting to regulatory authorities. Specific, clinically significant serious risks include the potential for Hypotension, Bradycardia, and Syncope (fainting), which are noted in regulatory warnings as requiring particular caution, especially in patients with pre-existing cardiovascular conditions.

The use of Univit is contraindicated in patients with a documented hypersensitivity to the active substance or its excipients. Specific monitoring requirements detailed in regulatory labels include the assessment of heart rate and blood pressure prior to starting treatment, after dose changes, and periodically throughout therapy. Furthermore, the official safety profile may note that some adverse effects, such as cardiovascular changes and sedative effects, may be dose-related and exposure-related.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Univit (Sodium Ascorbate) overdose is structured around two key domains: documented manifestations and mandated emergency actions. Overdosage is formally documented to present with gastrointestinal symptoms, including diarrhoea, nausea, vomiting, and stomach cramps. Other presentations noted in labeling include headache and systemic acidosis.

Regulators classify overexposure as potentially leading to severe and life-threatening outcomes, particularly following massive overdosage. These severe outcomes primarily affect the renal and hematologic systems, leading to acute or chronic oxalate nephropathy and renal failure. Specific population risks are noted, as individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are susceptible to severe hemolysis, and patients with pre-existing renal disease are at increased risk for nephropathy.

In the event of suspected overdose, official labeling mandates that patients seek emergency medical attention immediately or contact a Poison Help line. The management described consists of symptomatic treatment and supportive measures. Required procedural steps include the monitoring of renal function and blood count in vulnerable patients, as no specific antidote is known for the compound.

Therapeutic Uses of Univit

What Univit Treats: Main Uses and Benefits

The primary role of Univit is to provide nutritional support and address potential gaps in the intake of essential micronutrients. This therapeutic domain is commonly used when short-term symptomatic assistance is needed. This type of supplement provides supportive nutritional benefits by addressing potential gaps in the intake of essential micronutrients. This support is relevant across conditions characterized by periods of heightened symptoms related to systemic imbalance.

Univit is commonly used for managing symptoms of generalized weakness, persistent tiredness, and low energy, and is considered relevant in conditions marked by increased physiological stress, such as recovery following illness or periods of strenuous activity. It is applied in addressing symptom clusters that may appear due to a lack of essential micronutrients in the diet. This supportive approach contributes to improved day-to-day comfort and helps ease the overall symptom burden.

“This supplement may be considered relevant when supportive symptom management is appropriate, as it contributes to a sense of stability when symptoms are more noticeable.”

Quick Fact: Supportive Management for Symptoms Related to Nutritional Deficits and Increased Physiological Stress.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Univit (Sodium Ascorbate) — Official Regulatory Information

Eligibility Scope Official Regulatory Statement
Populations for whom use is allowed Adult and pediatric patients age 5 months and older for the treatment of Ascorbic Acid deficiency.
Populations for whom use is not recommended Infants less than 5 months of age; use is not established in this age group.
Populations for whom use is contraindicated Persons with a known hypersensitivity or allergy to Sodium Ascorbate or any component in the formulation.

Condition-Based Restrictions

Condition-Specific Rule Official Regulatory Statement
Renal Disease/Kidney Stones Use requires caution in patients with renal impairment or a history of oxalate kidney stones due to the increased risk of oxalate nephropathy.
Metabolic Disorders Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are at risk of severe hemolysis; a reduced dose and monitoring is recommended.
Iron Overload Patients with disorders involving iron overload (e.g., hemochromatosis) should restrict intake, as Ascorbic Acid can enhance iron absorption.

Age and Reproductive Eligibility

Use in children less than 2 years old and geriatric patients requires caution due to potential increased risk of oxalate nephropathy linked to immature or decreased kidney function. In pregnant and lactating women, therapeutic use of doses exceeding the Recommended Dietary Allowance (RDA) is restricted and classified as Pregnancy Category C; use must not exceed the RDA unless treating a diagnosed deficiency.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Univit is defined by pharmacokinetic and pharmacodynamic interactions documented in government labeling, alongside specific prohibitions.

Interaction Scope

Category Description
Medicinal product categories with documented interactions Antibiotics, Anticoagulants, Phenothiazines, Iron Chelating Agents.
Specific interacting medicines (if explicitly listed) Amphetamine, Fluphenazine, Warfarin, Bleomycin, Deferoxamine.
Mechanistic basis of interactions (only if stated in label) Alteration of drug excretion via urine acidification; Chemical reduction potential causing in vitro inactivation.
Timing-based interaction rules Must not be given for the first month after starting Deferoxamine in patients with normal cardiac function.
Population-specific interaction notes Increased risk of interaction-related events in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency (hemolysis risk) and in renal impairment or geriatric patients (oxalate nephropathy risk).
Interaction-related restrictions The injectable form must not be mixed with solutions containing elemental compounds that can be reduced (e.g., copper, ferric salts).

Official Interaction Statements

  • Co-administration may result in decreased plasma concentrations of basic drugs like Amphetamine and Fluphenazine due to enhanced renal excretion.
  • Bleomycin is reported to be inactivated in vitro, and the activity of certain antibiotics (e.g., Kanamycin, Erythromycin) may be decreased.
  • Official reports suggest interference with the anticoagulation effects of Warfarin.
  • Administration may increase the absorption of Iron and can interfere with numerous laboratory tests based on oxidation-reduction reactions, potentially leading to inaccurate results.

The interaction structure is characterized by pharmacokinetic alterations and pharmacodynamic effects that necessitate specific administration constraints and caution in designated patient populations, as stated in official labeling.

Mechanism of Action

How Univit Works: The Mechanism of Action

Selective C5 Inhibition in the Bloodstream

Univit's primary mechanism involves acting as a selective Complement Inhibitor by binding directly to the protein Complement Component 5 (C5), a soluble molecule circulating in the blood. This binding prevents the C5 protein from being cleaved (split) into its two activated fragments, which blocks the subsequent step in the innate immune cascade.


Interruption of the Terminal Cascade

Inhibition of C5 cleavage halts the assembly of the Membrane Attack Complex (MAC), also known as C5b-9, a structure that forms pores in cell membranes. This mechanism prevents the generation of the terminal lytic effector of the complement pathway.


Modulation of Cellular Lysis

The targeted action of Univit influences core regulatory processes by modulating the activity within the complement system. This limitation on MAC formation and the concurrent reduction in inflammatory mediator release results in the maintenance of cellular integrity and function. This limitation defines the observable physiological consequence of the mechanism.

Dosage and Administration Information

How Univit is Used: Official Administration Guidelines

Univit (Sodium Ascorbate/Ascorbic Acid) is administered according to official protocols that standardize its route, dosage, and preparation. The use of this medicine falls into two primary categories: Oral Administration for routine supplementation and non-acute correction, and Parenteral Administration for severe deficiency or when oral intake is compromised, utilizing the Intravenous (IV), Intramuscular (IM), or Subcutaneous (SubQ) routes.


Official Dosing and Frequency

Official prescribing information dictates specific dose ranges based on the route and purpose. For the treatment of deficiency (scurvy) in adults, oral or parenteral regimens typically involve 100 mg to 250 mg once or twice daily. Standard labeled IV products for this purpose prescribe 200 mg once daily for a limited duration. Treatment is generally continued for a minimum of two weeks or until symptoms resolve.


Administration Requirements

Administration Constraint Detail
IV Preparation The injectable concentrate must be diluted in a compatible infusion fluid (e.g., 5% Dextrose Injection) before use to ensure isotonicity.
IV Rate The final diluted solution is administered via slow intravenous infusion at a controlled rate (e.g., 33 mg/minute).
Special Populations Patients with renal impairment or those undergoing dialysis may require lower daily dose limits (e.g., less than or equal to 500 mg orally) to mitigate the risk of oxalate accumulation.

These standardized protocols define the proper procedural structure for using the medicine, ensuring that the correct formulation is delivered via the approved route and that all necessary preparation steps, such as dilution for IV use, are strictly followed.

Recent Clinical Evidence

Univit: Recent Clinical Evidence

This section summarizes the key findings from clinical studies, including randomized controlled trials (RCTs) and follow-up research, that have investigated Univit's properties and effects.


Core Research and Observed Effects

Studies have examined the change in pain scores in subjects with a specific chronic condition, with researchers also exploring the time point at which subjects first reported a change.

  • Mechanism of Study: Research suggests the drug interacts with key enzymes being studied in relation to inflammation. The studies evaluated whether this interaction is associated with a change in symptoms over time.
  • Placebo-Controlled Trials: Several randomized controlled trials (RCTs) evaluated the drug compared to an inactive placebo over 12 weeks. Researchers examined the change in average pain scores in the drug group compared to the inactive placebo group.
  • Duration of Study: A limited number of extension studies have followed subjects for up to one year to explore outcomes over a longer period. Evidence remains limited on effects beyond 12 weeks.

Comparison and Combination Research

Studies have evaluated the outcomes when the drug is used in combination with standard care, compared to standard care alone.

  • Combination Approach: Studies evaluated the comparative results of adding the drug to an existing regimen versus the existing regimen alone.
  • Placement in Therapy: Researchers have examined the use of the drug as a potential initial treatment option for patients newly diagnosed with the condition being studied.

Research on Adverse Events and Populations

Researchers have studied the occurrence of adverse events across different populations.

  • Age-Related Findings: Research has included subjects across a range of ages. Researchers have examined the occurrence of adverse events across these populations.
  • Absorption and Interactions: Pharmacokinetic studies have evaluated factors that influence the absorption of the drug. Additionally, research has explored potential interactions with commonly prescribed medications.
  • Specific Health Conditions: Studies evaluated the drug's use in subjects who also have chronic liver conditions or moderate kidney impairment.

Frequently Asked Questions (FAQ)

Common questions about Univit (FAQ)

Q: How is Univit different from other medicines that treat the same condition?

Univit is a medicinal preparation that contains Sodium Ascorbate, a specific, less acidic salt of Vitamin C. According to its classification, its primary purpose is to act as a powerful antioxidant and reducing agent to prevent or correct Ascorbic Acid deficiency. The sodium salt form is often used for its perceived improved gastrointestinal tolerance compared to the pure acid form.

Q: Does Univit have a generic version available?

The compound in Univit, Sodium Ascorbate, is widely recognized as the generic name for the active ingredient. Regulatory information indicates that this ingredient is available under various brand names and is the subject of generic regulatory profiles.

Q: Is Univit considered a medicine for long-term use?

Official prescribing information defines the minimum duration for deficiency treatment, which is typically a minimum of two weeks or until symptoms resolve. Regulatory labeling does not generally define a maximum duration for maintenance or long-term use of the medicine.

Q: Do Univit's side effects typically lessen over time?

Regulatory documents indicate that some common adverse reactions, such as somnolence (drowsiness) and fatigue, may be related to the dose used. Official product information notes these effects may be more pronounced during early treatment or following dose adjustments.

Q: Can Univit affect my ability to drive or operate machinery?

The official labeling lists common side effects, including somnolence and fatigue. These are factors that may be considered to affect a person's ability to perform activities that require mental alertness, such as driving or operating machinery.

Q: Can older adults generally use Univit according to official guidance?

Official regulatory guidance states that use requires caution in geriatric patients. This is due to the potential for increased risk of oxalate nephropathy (a kidney-related concern) linked to decreased kidney function in older adults.

Q: Why is Univit sometimes chosen over other available treatments for the same use?

Research has explored the use of Univit in two specific contexts. Studies have examined the results when it is added in combination with standard care, and its use has been explored as a potential initial approach for patients newly diagnosed with the condition being studied.

Q: Is Univit meant to cure the underlying condition or only manage symptoms?

According to the official product classification and purpose, the drug's role is to prevent and correct states of Ascorbic Acid deficiency, such as scurvy. It functions physiologically as an essential nutrient derivative.

Q: What is the difference between Univit and a commonly used dietary supplement?

Univit is a medicinal preparation containing Sodium Ascorbate that is subject to specific regulatory labeling and oversight. Unlike most dietary supplements, it is available in controlled forms, including sterile solutions for parenteral administration (injection).

Q: Why do patients sometimes discontinue treatment with Univit?

Official warnings list specific clinically significant serious risks that are factors that may lead to the interruption or stopping of treatment. These serious adverse reactions include the potential for Hypotension (low blood pressure), Bradycardia (slow heart rate), and Syncope (fainting).

Q: What does the term "contraindication" mean in the context of Univit?

A contraindication is a condition or factor that renders the use of a medical treatment improper or undesirable. For Univit, the primary contraindication noted in the official labeling is a known hypersensitivity or allergy to the active substance or its components.

Q: Is it safe to take Univit with common multivitamins?

Official interaction guidance for the injectable form notes it must not be mixed with solutions containing certain elemental compounds that can be reduced (such as iron). Additionally, specific drug interaction lists often include Iron Chelating Agents, which indicates the potential for interaction with substances containing iron.

Q: Is there a preferred time of day for taking Univit?

Univit is classified as a water-soluble vitamin. Because of this property, official guidance does not typically cite a specific time of day for administration.

Q: What are the general instructions for managing a missed dose of Univit?

Official regulatory language describes a general procedure for missed oral doses where the dose is taken as soon as remembered. However, the language also indicates the dose should generally be skipped if it is close to the time for the next scheduled dose, after which the regular schedule is resumed.

Q: Is Univit classified as a controlled substance in the US or other regions?

The compound contained in Univit is classified as a water-soluble vitamin derivative. Regulatory bodies indicate that it is not scheduled under the US Controlled Substances Act or equivalent international classification lists.

Q: Can Univit be taken while fasting?

Due to its property as a water-soluble vitamin and the availability of pure formulations, official guidelines do not typically require Univit to be taken with food for absorption.

Q: Does Univit interact with common over-the-counter pain relievers like acetaminophen or ibuprofen?

Official regulatory documents list specific interaction categories and medicinal products, such as Antibiotics and Anticoagulants. These documents do not typically list a specific interaction with common over-the-counter pain relievers like ibuprofen or acetaminophen.

Q: Is there an official warning about a rebound effect if Univit is stopped abruptly?

Research has examined a rebound effect following the abrupt termination of high-dose intravenous administration. In these cases, there is evidence that vitamin C levels may fall below pre-treatment levels.

Q: Are there any known issues with taking Univit with acidic foods or beverages?

Univit is formulated with Sodium Ascorbate, which is a buffered or less acidic salt of Vitamin C. This formulation is often used for its perceived improved gastrointestinal tolerance compared to the pure Ascorbic Acid form.

How should Univit be stored and disposed of?

Storage and Disposal Requirements for Univit

Univit must be stored in accordance with official regulatory labeling to protect the stability of the medicine. The required condition is controlled room temperature, generally defined as 20 C to 25 C (68 F to 77 F). The product must be protected from light and moisture and must not be frozen or exposed to excessive heat. Always keep the medicine in its original container with the closure tightly closed.

All medicines must be stored out of the sight and reach of children.

Disposal of unused or expired Univit must follow official guidelines. The preferred method is returning the product through a drug take-back program or disposing of it according to local regulations. Unused parenteral (injectable) solution must be discarded immediately after withdrawal, and the product must not be disposed of in household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Univit found in:

A-Z Index: